{
    "applicationNumber": "BR 11 2021 001117-0",
    "filingDate": "22/07/2019",
    "grantDate": null,
    "title": "C\u00c9LULAS CANCER\u00cdGENAS MODIFICADAS, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, LINHA CELULAR, M\u00c9TODOS PARA FAZER C\u00c9LULAS CANCER\u00cdGENAS MODIFICADAS E PARA ESTIMULAR UMA RESPOSTA IMUNE, VETOR DE EXPRESS\u00c3O ISOLADO OU COMBINA\u00c7\u00c3O DE VETORES DE EXPRESS\u00c3O ISOLADOS, E, UMA OU MAIS C\u00c9LULAS CANCER\u00cdGENAS MODIFICADAS",
    "nationalPhaseDate": [
        "21/01/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2019/042764",
        "pctDate": "22/07/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/701,791",
            "priorityDate": "22/07/2018"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2613"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2624"
        }
    ],
    "inventors": [
        "KUNLE ODUNSI",
        "TAKEMASA TSUJI",
        "JUNKO MATSUZAKI"
    ],
    "holders": [
        88079
    ],
    "ipcCodes": [
        "A61K 38/16",
        "C12Q 1/68",
        "C12N 15/79",
        "C12N 5/07",
        "C12N 15/85",
        "A61K 38/19",
        "C12N 5/16",
        "C12N 5/071",
        "C12N 15/86",
        "C12N 5/09"
    ]
}